
Zeltel 3D 40mg/5mg/12.5mg Tablet
Marketer
Zelnic Biotech Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Zeltel 3D 40mg/5mg/12.5mg Tablet
Trilyte-HP 40mg/5mg/12.5mg tablets combine multiple medications to effectively manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, significantly reducing the risk of future cardiovascular events such as stroke and myocardial infarction. Trilyte-HP may be taken with or without food; dosage is individualized based on patient response and health status. Consistent daily dosing is recommended. Continue treatment as directed by your physician; premature discontinuation increases stroke and heart attack risk. The medication includes a diuretic, increasing urinary output; therefore, avoid late-evening administration. Regular use maximizes therapeutic benefits, even during asymptomatic periods, as hypertension often lacks overt symptoms. Common side effects may include headache, dizziness, lethargy, altered taste perception, fatigue, influenza-like symptoms, diarrhea, and sinusitis. Report any persistent, worsening, or bothersome side effects to your doctor. Adequate hydration is crucial to mitigate potential side effects like muscle weakness, dry mouth, and excessive thirst. Prior to initiating therapy, disclose any pre-existing renal or hepatic impairment. Pregnant or lactating individuals must consult their physician before use. Inform your doctor about all concurrent medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, renal function, electrolyte levels, and blood glucose is essential to ensure optimal treatment efficacy and safety.
Primary Ingredients of Zeltel 3D 40mg/5mg/12.5mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Zeltel 3D 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Zeltel 3D 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Zeltel 3D 40mg/5mg/12.5mg Tablet whole; avoid crushing, chewing, or breaking it. This medication can be administered with or without food, though consistent timing is recommended.
Common Side effects of Zeltel 3D 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Zeltel 3D 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Zeltel 3D 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
How Zeltel 3D 40mg/5mg/12.5mg Tablet works:
Each Zeltel 3D 40mg/5mg/12.5mg tablet contains telmisartan, amlodipine, and hydrochlorothiazide, which act synergistically to reduce blood pressure. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both promote vasodilation, easing blood vessel constriction. Hydrochlorothiazide, a diuretic, lowers blood pressure by increasing urine output, eliminating excess fluid and electrolytes, and contributing to long-term vasodilation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Zeltel 3D 40mg/5mg/12.5mg Tablet is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Use of Zeltel 3D 40mg/5mg/12.5mg tablets is contraindicated during pregnancy due to confirmed fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingUNSAFE
The combination drug Zeltel 3D (40mg/5mg/12.5mg tablets) is contraindicated for breastfeeding mothers due to the potential for infant harm from its components.
DrivingUNSAFE
Driving ability may be impaired by Zeltel 3D 40mg/5mg/12.5mg Tablets, due to potential side effects including dizziness, headache, nausea, or fatigue, which can negatively impact concentration.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Zeltel 3D 40mg/5mg/12.5mg tablets, as dose modification may be necessary. A physician's consultation is advised. Zeltel 3D 40mg/5mg/12.5mg tablets are not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Tri-Component Tablet (40mg/5mg/12.5mg) cautiously. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Zeltel 3D 40mg/5mg/12.5mg Tablet :
Should you forget to take a Zeltel 3D 40mg/5mg/12.5mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zeltel 3D 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
